Kawabuchi Y - Search Results

1

Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.

Kawabuchi Y, Yamaguchi Y, Ohshita A, Minami K, Toge T. Kawabuchi Y, et al. Anticancer Res. 2004 Mar-Apr;24(2C):1193-200. Anticancer Res. 2004. PMID: 15154646 Free article.

2

[Generation of TRiDAK (tumor RNA-introduced dendritic cell-activated killer) cells].

Ohshita A, Yamaguchi Y, Minami K, Miyahara E, Kawabuchi Y, Shimizu K, Ohta K, Hihara J, Toge T. Ohshita A, et al. Among authors: kawabuchi y. Gan To Kagaku Ryoho. 2003 Oct;30(11):1809-12. Gan To Kagaku Ryoho. 2003. PMID: 14619526 Japanese.

3

Adoptive immunotherapy of cancer using activated autologous lymphocytes--current status and new strategies.

Yamaguchi Y, Ohshita A, Kawabuchi Y, Ohta K, Shimizu K, Minami K, Hihara J, Miyahara E, Toge T. Yamaguchi Y, et al. Among authors: kawabuchi y. Hum Cell. 2003 Dec;16(4):183-9. doi: 10.1111/j.1749-0774.2003.tb00152.x. Hum Cell. 2003. PMID: 15147038 Review.

4

Enhancing effect of PS-K on IL-2-induced lymphocyte activation: possible involvement of antagonistic action against TGF-beta.

Yamaguchi Y, Minami K, Ohshita A, Kawabuchi Y, Noma K, Toge T. Yamaguchi Y, et al. Among authors: kawabuchi y. Anticancer Res. 2004 Mar-Apr;24(2B):639-47. Anticancer Res. 2004. PMID: 15161006 Free article.

5

Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.

Yamaguchi Y, Ohta K, Kawabuchi Y, Ohshita A, Okita R, Okawaki M, Hironaka K, Matsuura K, Toge T. Yamaguchi Y, et al. Among authors: kawabuchi y. Anticancer Res. 2005 May-Jun;25(3c):2407-15. Anticancer Res. 2005. PMID: 16080467 Free article. Clinical Trial.

6

Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA.

Minami K, Yamaguchi Y, Ohshita A, Kawabuchi Y, Ohta K, Hihara J, Toge T. Minami K, et al. Among authors: kawabuchi y. Oncology. 2005;69(5):399-407. doi: 10.1159/000089994. Epub 2005 Nov 24. Oncology. 2005. PMID: 16319511

7

[Tumor RNA introduction into dendritic cells and Epstein-Barr virus transformed B cells].

Minami K, Yamaguchi Y, Ohshita A, Kawabuchi Y, Shimizu K, Ohta K, Hihara J, Miyahara E, Toge T. Minami K, et al. Among authors: kawabuchi y. Gan To Kagaku Ryoho. 2003 Oct;30(11):1813-6. Gan To Kagaku Ryoho. 2003. PMID: 14619527 Japanese.

8

Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.

Yamaguchi Y, Ohshita A, Kawabuchi Y, Hihara J, Miyahara E, Noma K, Toge T. Yamaguchi Y, et al. Among authors: kawabuchi y. Int J Oncol. 2004 Apr;24(4):959-66. Int J Oncol. 2004. PMID: 15010836

9

Anterior resection of rectal cancer through a one hand-size incision with or without laparoscopy: proposal of one hand-size incision surgery (OHaSIS).

Yamaguchi Y, Minami K, Kawabuchi Y, Emi M, Toge T. Yamaguchi Y, et al. Among authors: kawabuchi y. J Surg Res. 2005 Nov;129(1):136-41. doi: 10.1016/j.jss.2005.04.039. Epub 2005 Jun 14. J Surg Res. 2005. PMID: 15961105

10

Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus interleukin-2: induction of autologous tumor-reactive CD4+ Th1 killer lymphocytes.

Yamaguchi Y, Miyahara E, Ohshita A, Kawabuchi Y, Ohta K, Shimizu K, Minami K, Hihara J, Sawamura A, Toge T. Yamaguchi Y, et al. Among authors: kawabuchi y. Br J Cancer. 2003 Nov 17;89(10):1876-84. doi: 10.1038/sj.bjc.6601379. Br J Cancer. 2003. PMID: 14612896 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page